
# Title 37 - Patents, Trademarks, and Copyrights
## Chapter I - United States Patent and Trademark Office, Department of Commerce
### Subchapter A - General
#### PART 1 - RULES OF PRACTICE IN PATENT CASES
##### Subpart G - Biotechnology Invention Disclosures
###### Application Disclosures Containing Nucleotide and/or Amino Acid Sequences
####### § 1.835 Amendment to add or replace a "Sequence Listing XML" in patent applications filed on or after July 1, 2022.
######## see

(2) A request to amend the specification to include an incorporation by reference statement of the material in the "Sequence Listing XML" file, identifying the name of the file, the date of creation, and the size of the file in bytes (§ 1.77(b)(5)(ii)), except when submitted to the United States International Preliminary Examining Authority for an international application;

(3) A statement that indicates the basis for the amendment, with specific references to particular parts of the application as originally filed (specification, claims, drawings) for all sequence data in the "Sequence Listing XML"; and

(4) A statement that the "Sequence Listing XML" includes no new matter.

(b) Any amendment adding to, deleting from, or replacing sequence information in a "Sequence Listing XML" submitted as required by § 1.831(a) must include:

(1) A replacement "Sequence Listing XML" in accordance with the requirements of §§ 1.831 through 1.834 containing the entire "Sequence Listing XML," including any additions, deletions, or replacements of sequence information, which shall be submitted:

(i) Via the USPTO patent electronic filing system; or

(ii) On a read-only optical disc, in compliance with § 1.52(e), labeled as "REPLACEMENT MM/DD/YYYY" (with the month, day, and year of creation indicated);
